Context dependent interactions between protozoan infections and cancer biology-a retrospective review
- 1The First Affiliated Hospital, Dalian Medical University
- 2College of Basic Medical Science, Dalian Medical University
- 3The Second Affiliated Hospital, Dalian Medical University
Abstract
Protozoan infections can influence tumor biology through immune modulation, effects on tumor cells and vasculature, and changes in mucosal homeostasis. The supporting evidence, however, differs substantially among organisms and experimental settings. Selected studies of Toxoplasma gondii, Plasmodium species, and Trypanosoma cruzi demonstrate tumor suppression in cell and animal models, including immune activation, altered myeloid-cell function, and inhibition of angiogenesis. Associations between intestinal or urogenital protozoa and human cancers are mainly observational and do not establish carcinogenesis. Malaria associated with Plasmodium falciparum in holoendemic areas provides a distinct cancer-associated context that cannot be equated with experimental antitumor interventions. This narrative review distinguishes population associations, mechanistic observations, causal evidence within experimental models, and human therapeutic investigation. It evaluates strain or subtype, infection burden and duration, tissue tropism, host immune status, and observation timing as candidate modifiers rather than universally validated determinants. Direct tumor-cell effects, vascular effects, and host-immune-mediated effects are considered separately. Particular attention is given to inconsistent Trichomonas vaginalis and Blastocystis findings, limitations of murine models, confounding and reverse causation, and the safety of live-organism approaches in immunocompromised patients. Registered Plasmodium-based oncology studies demonstrate clinical investigation, but registration does not establish therapeutic benefit. Most engineered parasites and parasite-derived platforms discussed remain preclinical. The proposed framework organizes heterogeneous evidence and identifies testable questions for safer translational research; it does not imply that natural protozoan infection provides a predictable clinical benefit.
Related
- High prevalence of intestinal protozoan infections among asymptomatic individuals in rural and urban communities in conflict-affected Northwest Cameroon.
- Population density is a selective driver of urban soil microbiomes: evidence from bacteria, fungi and protozoan communities in a regional city
- Same Factor, Different Branches: Context-Dependent Control of Dendritic Development by Lhx2
- Multilayer interaction networks reveal multidimensional ecological strategies and context-dependent competition in soil actinobacteria
- Context-dependent regulation of cytotoxic T lymphocytes by nuclear receptors
BibTeX
@article{yu2026context,
title = {{Context dependent interactions between protozoan infections and cancer biology-a retrospective review}},
author = {Fanglei Yu and Zheng Wu and Yaru Huang and Xiaochen Qi and Jun Wu and Yuanhua Qin},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1968151},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1968151/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Context dependent interactions between protozoan infections and cancer biology-a retrospective review
AU - Fanglei Yu
AU - Zheng Wu
AU - Yaru Huang
AU - Xiaochen Qi
AU - Jun Wu
AU - Yuanhua Qin
PY - 2026
DA - 2026/10/09
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1968151
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1968151/full
AB - Protozoan infections can influence tumor biology through immune modulation, effects on tumor cells and vasculature, and changes in mucosal homeostasis. The supporting evidence, however, differs substantially among organisms and experimental settings. Selected studies of Toxoplasma gondii, Plasmodium species, and Trypanosoma cruzi demonstrate tumor suppression in cell and animal models, including immune activation, altered myeloid-cell function, and inhibition of angiogenesis. Associations between intestinal or urogenital protozoa and human cancers are mainly observational and do not establish carcinogenesis. Malaria associated with Plasmodium falciparum in holoendemic areas provides a distinct cancer-associated context that cannot be equated with experimental antitumor interventions. This narrative review distinguishes population associations, mechanistic observations, causal evidence within experimental models, and human therapeutic investigation. It evaluates strain or subtype, infection burden and duration, tissue tropism, host immune status, and observation timing as candidate modifiers rather than universally validated determinants. Direct tumor-cell effects, vascular effects, and host-immune-mediated effects are considered separately. Particular attention is given to inconsistent Trichomonas vaginalis and Blastocystis findings, limitations of murine models, confounding and reverse causation, and the safety of live-organism approaches in immunocompromised patients. Registered Plasmodium-based oncology studies demonstrate clinical investigation, but registration does not establish therapeutic benefit. Most engineered parasites and parasite-derived platforms discussed remain preclinical. The proposed framework organizes heterogeneous evidence and identifies testable questions for safer translational research; it does not imply that natural protozoan infection provides a predictable clinical benefit.
SN - 1664-3224
ER -